Open AccessLipid profile outcome gaps of Arabs and South Asians receiving chronic Statin therapy
Author(s) -
Zahra Alagheband,
Seeba Zachariah,
Dixon Thomas,
Dave L. Dixon
Publication year - 2020
Publication title -
international journal of research in pharmaceutical sciences
Language(s) - English
Resource type - Journals
ISSN - 0975-7538
DOI - 10.26452/ijrps.v11ispl4.4442
Subject(s) - dyslipidemia , medicine , lipid profile , statin , body mass index , population , cohort , cohort study , demography , cholesterol , traditional medicine , obesity , environmental health , sociology
Ethnicity is a variable in statin response, but the influence of it in Arabs and South Asians is not known. There is a possibility of under-treatment in the long-term management of dyslipidemia in the Arab population, ignoring post-initiation medication nonadherence and lifestyle. There could be potential genetic reasons also for the need for higher lipid-lowering therapy in Arabs. This study is to identify lipid profile outcome gaps of Arabs and South Asians who were receiving chronic statin therapy. A hypothesis generating retrospective cohort study was conducted to compare lipid profiles among patients treated with a statin for more than three months. The study compared two lipid profiles of Arab and South Asian patients on chronic management of dyslipidemia. T-test and Z-test were performed to compare the lipid profiles. The study participants included 42 Arabs and 28 South Asians. Arabs had a higher body mass index (P-value 0.05), and more of them were smokers compared to South Asians (P-value 0.04). Total cholesterol (P-value 0.03, 95%CI 1.08 to -21.29) and LDL cholesterol (P-value 0.03, 95% CI 0.51 to -17.51) reductions in 3 – 6 months were significant in South Asians, but not in Arabs. The lipid profiles in Arabs receiving chronic statin therapy might be poor compared to South Asians. Both populations need improvements in lipid-lowering therapy outcomes. This hypothesis should be studied further to prove inherent differences and poor therapy outcomes among Arab and South Asian population that might result in modifications in current healthcare management policies.